| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $573.2M | +16.8% |
| Cost of Revenue | $334.8M | +22.9% |
| Gross Profit | $238.4M | +9.1% |
| R&D Expense | $98.0M | +77.6% |
| SG&A Expense | $68.0M | -40.2% |
| Operating Income | -$24.3M | -987.3% |
| Interest Expense | $5.2M | -81.8% |
| Income Tax | -$2.3M | +40.9% |
| Net Income | $19.6M |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $113.6M | -65.7% |
| Short-term Investments | $71.2M | — |
| Accounts Receivable | $74.5M | +20.9% |
| Current Assets | $279.6M | -32.3% |
| Total Assets | $929.3M | -12.8% |
| Current Liabilities | $114.0M | +21.9% |
| Long-term Debt | $480.5M | -1.2% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $34.9M | -14.5% |
| Investing Cash Flow | -$133.4M | -4810.5% |
| Financing Cash Flow | -$120.0M | -158.0% |
| +171.5% |
| EPS (Basic) | $0.77 | +170.6% |
| EPS (Diluted) | -$0.48 | +56.0% |
| Total Liabilities |
| $657.1M |
| +0.6% |
| Stockholders' Equity | $272.2M | -34.0% |